Immunologic tests in patients after clinical cure of visceral leishmaniasis

American Journal of Tropical Medicine and Hygiene

Volumn 75, Issue 4, 2006, Pages 739-743

  Silva, Luciana De Almeida ^a   Romero, Héctor Dardo ^a   Prata, Aluízio ^a   Costa, Roberto Teodoro ^b   Nascimento, Evaldo ^b   Carvalho, Sílvio Fernandes Guimarães ^c   Rodrigues, Virmondes ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Montes Claros State University   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AMPHOTERICIN B; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; IMMUNOLOGICAL PROCEDURES; INFANT; LEISHMANIASIS; MALE; PROMASTIGOTE; RECURRENT DISEASE; SEROLOGY; SKIN TEST; VISCERAL LEISHMANIASIS; ANIMAL; DOG; DRUG COMBINATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; TIME;

NASO HEXACANTHUS;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY; DOGS; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOLOGIC TESTS; INFANT; LEISHMANIASIS, VISCERAL; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RECURRENCE; SKIN TESTS; TIME FACTORS;

EID: 33750610214     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.75.739     Document Type: Article

References (30)

1. Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB, 2000. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal. Am J Trop Med Hyg 63: 153-157.
2. Kaul P, Malla N, Kaur S, Mahajan RC, Ganguly NK, 2000. Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent (ELISA) for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 94: 173-175.
3. Singh S, Gilman-Sachs A, Chang KP, Reed SG, 1995. Diagnostic and prognostic value of K39 recombinant antigen in indian leishmaniasis. J Parasitol 81: 1000-1003.
4. Singh S, Kumari V, Singh N, 2002. Predicting kala-azar disease manifestation in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant k39 antigen. Clin Diagn Lab Immunol 9: 568-572.
5. Singh S, Sivakumar R, 2003. Recent advances in the diagnosis of leishmaniasis. J Postgrad Med 49: 55-66.
6. Sundar S, Rai M, 2002. Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 9: 951-958.
7. Hailu A, 1990. Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans R Soc Trop Med Hyg 84: 673-675.
8. Oskam L, Niewenhuijs JL, Hailu A, 1999. Evaluation of the direct agglutination test (DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in stored sera from various groups in Ethiopia. Trans R Soc Trop Med Hyg 93: 275-277.
9. Badaró R, Carvalho EM, Orge MGO, Teixiera RS, Rocha H, 1985. Imunidade humoral e celular em indivíduos curados de leishmaniose visceral. Rev Soc Bras Med Trop 18: 77-83.
10. Zerpa O, Ulrich M, Banitez M, Avila C, Rodriguez V, Centeno M, Belizario D, Reed SG, Convit J, 2002. Epidemiological and immunological aspects of human visceral leishmaniasis on Margarita Island, Venezuela. Mem Inst Oswaldo Cruz 97: 1079-1083.
11. Zijlstra EE, Daifalla NS, Kager PA, Khalil EAG, El-Hassan AM, Reed SG, Ghalib HW, 1998. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol 5: 717-720.
12. Pampiglione S, Manson-Bahr PEC, Placa M, Borgatti MA, Musumeci S, 1975. Studies on Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg 69: 447-453.
13. Prata A, 1957. Quadro Clínico e Laboratorial do Calazar. Arquivos Brasileiros de Medicina Naval. 65: 11-26.
14. Levy L, Mendes E, 1981. Impaired cell-mediated immunity in patients with Kala-azar. Allergol Immunopathol (Madr) 9: 109-112.
15. Manson-Bahr PEC, Southgate BA, 1964. Recent research on Kala Azar in East Africa. J Trop Med Hyg 67: 79-84.
16. Southgate BA, Oriedo VEB, 1967. Studies in the epidemiology of East African Leishmaniasis. 3. Immunity as a determinant of geographical distribution. J Trop Med Hyg 70: 1-4.
17. Southgate BA, Manson-Bahr PEC, 1967. Studies in the epidemiology of East African Leishmaniasis. 4. The significance of the positive leishmanin test. J Trop Med Hyg 70: 29-33.
18. Shido SA, Akuffo HO, Mohamed AA, Huldt G, Nilsson LA, Ouchterlony O, Thorstensson R, 1995. Visceral leishmaniasis in Somalia: Prevalence of leishmanin-positive and seropositive inhabitants in an endemic area. Trans R Soc Trop Med Hyg 89: 21-24.
19. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD, 1986. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154: 639-649.
20. D'Oliveira A, Costa SRM, Barbosa AB, Orge MGO, Carvalho EM, 1997. Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis. Mem Inst Oswaldo Cruz 92: 15-20.
21. Marzochi KBF, Marzochi MCA, Schubach AO, 1999. Leishmaniose visceral: interação hospedeiro-parasito e determinismo das formas clínicas. Rev Soc Bras Med Trop 32 (Suppl 2): 59.
22. Melo MN, Mayrink W, Costa CA, Magalhães PA, Dias M, Williams P, Araújo FG, Coelho MV, Batista SM, 1977. Padronização do antígeno de Montenegro. Rev Inst Med Trop Sao Paulo 19: 161-164.
23. Sokal JE, 1975. Editorial: Measurement of delayed skin-test response. N Engl J Med 293: 501-502.
24. Badaró R, Reed SG, Barral A, Orge MGO, Jones TC, 1986. Evaluation of micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: Antigen selection for detection of infection-specific response. Am J Trop Med Hyg 35: 72-78.
25. Hommel M, Peters W, Ranque J, Quilici M, Lanotte G, 1978. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol 72: 213-218.
26. Voller A, Bidwell DE, Bartlett A, 1976. Enzyme immunoassay in diagnostic medicine. Theory and practice. Bull World Health Organ 53: 55-65.
27. Camargo ME, 1966. Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo 8: 227-234.
28. Hailu A, Menon JN, Berhe N, Gedamu L, Hassard TH, Kager PA, Olobo J, Bretscher PA, 2001. Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: Implications for the mechanism underlying drug cure. J Infect Dis 184: 112-115.
29. Prata A, 1957. Cura parasitológica do calazar. Hospital (Rio J) 51: 571-577.
30. Alvar J, Canavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R, Molina R, Moreno J, 1997. Leishmania and human immunodeficiency virus coinfection: The first 10 years. Clin Microbiol Rev 10: 298-391.